COVID-19 Resource Center for Infectious Disease Clinicians

Hear expert insights on why extra doses and boosters of the SARS-CoV-2 vaccines are recommended for certain populations, and learn recommendations regarding mixing and matching booster doses.

Renslow Sherer, MD Released: December 8, 2021

Hear expert insights on the rationale for the use of monoclonal antibodies for postexposure prophylaxis in high-risk populations.

Arthur Kim, MD Released: December 15, 2021

Hear expert insights on the use of IV and oral antiviral agents for the treatment of nonhospitalized patients with COVID-19.

Sharon R. Lewin, AO, FRACP, PhD, FAHMS Released: January 6, 2022

Hear expert insights on a stepwise approach to evaluate treatment candidacy for oral antiviral agents for COVID-19 and practical considerations for their use.

Kristen Marks, MD Released: February 3, 2022

Hear expert insights on how the omicron variant is affecting monoclonal antibody treatments for COVID-19.

Arthur Kim, MD Released: February 21, 2022

Get expert insights on the symptoms, causes, risk factors, timeline, and treatment considerations for long COVID, or postacute sequelae of COVID-19 infection.

Renslow Sherer, MD Released: March 30, 2022

Hear expert insights on the latest data on and recommendations for second booster doses of COVID-19 vaccine. Learn which patients are eligible, which vaccines to administer, and timing of administration.

Kristen Marks, MD Released: May 20, 2022

Hear expert insights on the role of remdesivir for the treatment of nonhospitalized adult and pediatric patients with COVID-19.

Sharon R. Lewin, AO, FRACP, PhD, FAHMS Released: June 7, 2022

Hear expert insights on ivermectin as a treatment for COVID-19 and evolving information on monoclonal antibodies during the latest omicron wave.

Sharon R. Lewin, AO, FRACP, PhD, FAHMS Released: June 7, 2022

Hear expert insights on the latest data and updates regarding COVID-19 vaccines, including fourth doses, CDC recommendations, the availability of a new, non-mRNA vaccine, and authorization for our youngest pediatric patients.

Renslow Sherer, MD Released: August 1, 2022

Hear expert insights on oral antiviral efficacy in real-world populations and COVID-19 rebound phenomenon.

Arthur Kim, MD Released: August 5, 2022